Growing community of inventors

Hong Kong, China

Hsiang-Fu Kung

Average Co-Inventor Count = 3.69

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 10

Hsiang-Fu KungMing-Liang He (3 patents)Hsiang-Fu KungYi Guan (2 patents)Hsiang-Fu KungBo-Jiang Zheng (2 patents)Hsiang-Fu KungMarie Chia-Mi Lin (2 patents)Hsiang-Fu KungYing Peng (2 patents)Hsiang-Fu KungJun Huang (1 patent)Hsiang-Fu KungMarie C M Lin (1 patent)Hsiang-Fu KungCui-Fen Huang (1 patent)Hsiang-Fu KungHsiang-Fu Kung (4 patents)Ming-Liang HeMing-Liang He (5 patents)Yi GuanYi Guan (12 patents)Bo-Jiang ZhengBo-Jiang Zheng (3 patents)Marie Chia-Mi LinMarie Chia-Mi Lin (2 patents)Ying PengYing Peng (2 patents)Jun HuangJun Huang (9 patents)Marie C M LinMarie C M Lin (1 patent)Cui-Fen HuangCui-Fen Huang (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The University of Hongkong (4 from 329 patents)

2. Beijing Institute of Technology (1 from 143 patents)


4 patents:

1. 7429656 - Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference

2. 7294708 - Telomerase reverse transcriptase fragments and uses thereof

3. 7129223 - Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference

4. 7067249 - Inhibition of hepatitis B virus (HBV) replication by RNA interference

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…